Biotech Startups

Basepair is a SaaS bioinformatics platform that provisions in a customer's own AWS account to store and analyze genomic and next-generation sequencing (NGS) data without moving it, offering point-and-click and API-driven workflows plus interactive visualization. It serves healthcare and life-science research teams, including bench scientists and bioinformaticians, with prebuilt pipelines for genomics, transcriptomics, and epigenomics.

7 investors

Basepaws offers a DNA testing service for cats that analyzes genetic breed similarity and provides breed breakdown reports for mixed-breed and domestic cats. The test compares a cat's genetic sequence to known breed databases rather than confirming pedigree status.

7 investors

Berkeley Lights (now Bruker Cellular Analysis) develops the Beacon optofluidic system for single-cell functional analysis, enabling researchers to profile live single cells to discover therapeutic antibodies, interrogate T cells, identify cell therapies, and accelerate cell line development. Its platform serves biotech, pharma, and academic researchers across discovery, basic research, and translational research.

7 investors

Better Dairy uses precision fermentation to produce bioactive milk proteins optimized for human development, targeting applications such as infant formulas that more closely mimic breastmilk and supplements for workout recovery. The company positions its proteins as more environmentally sustainable, requiring less greenhouse gas emissions and water than conventional dairy.

7 investors

Graphica applies foundational AI models to precision plant breeding, genetics and molecular biology, building plants and biological products. The company combines plant scientists, computational biologists and engineers with computational, experimental and commercial expertise.

7 investors

BiomeSense builds an AI-enabled platform combining hardware (GutLab) and bioinformatics (MetaBiome) to continuously generate and analyze gut microbiome data. It serves scientists, institutions, and companies conducting clinical research on the microbiome for personalized biomarker discovery and product development.

7 investors

BIOS Health develops neural interfaces to read and apply nerve data for medical use, applying AI to precision medicine for the nervous system. Formerly known as Cambridge Bio-Augmentation Systems (CBAS), it initially focused on prosthetic neural interfaces.

7 investors

bitBiome provides contract analysis and collaborative research using single-cell genome sequencing technology for microbial samples. The company serves clients in biotech and related manufacturing sectors in Japan and the U.S.

7 investors

Blueprint Medicines is a biopharmaceutical company that discovers and develops targeted medicines for patients with diseases such as gastrointestinal stromal tumor and other conditions driven by genetic changes. It markets approved therapies internationally and runs patient access programs across multiple countries.

7 investors

MIT is an educational and research institution in Cambridge, Massachusetts, pursuing teaching, research, and innovation across science, engineering, and other fields. It serves undergraduate and graduate students and maintains a global community of faculty and researchers.

7 investors

Boost Biomes develops microbiome-based products using microbial community analysis to identify beneficial microbe interactions, with applications in agriculture. It operates in the biotech and agtech space.

7 investors

Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration. The company operates in the biotech and therapeutics space focused on pain control.

7 investors

Bugbiome develops crop protection products for farmers that aim to work with natural systems. The company focuses on sustainable agriculture and reducing the environmental impact of farming.

7 investors

Cache develops a platform for reliable long-term storage and access of biomolecules to support precision medicine and fundamental research. It aims to provide scalable, sustainable, and standardized biomolecule storage.

7 investors

CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).

7 investors

CatalYm develops immunotherapies for solid tumors by neutralizing GDF-15, a factor cancer cells use to suppress immune responses and resist treatment. Its lead antibody, visugromab, is being advanced through clinical trials in combination with anti-PD-1 therapies to overcome cancer therapy resistance.

7 investors

CB Therapeutics engineers microbes to biomanufacture high-value natural ingredients used in medicines, supplements, and wellness products. The company builds biological supply chains for rare natural compounds aimed at treating disease and supporting longevity.

7 investors

CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams. The company's platform enables more efficient and accessible production of cell therapies for treatment applications.

7 investors

Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.

7 investors

Cerevance develops precision novel therapeutics for central nervous system disorders, particularly neurodegenerative diseases, using its proprietary NETSseq platform and machine learning to identify targets from an extensive collection of human brain tissue samples. The company has multiple candidates in clinical development targeting Parkinson's disease, psychiatric conditions, ALS, and Alzheimer's disease.

7 investors

Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.

7 investors

Chunk Foods makes plant-based meat alternatives produced through fermentation, including a whole-cut product designed for slicing, slow-cooking, marinating, and roasting. The products use Non-GMO, clean-label ingredients and are high in protein and fiber.

7 investors

Coding Bio develops modular immunotherapies for cancer patients, using a high-throughput lab to screen millions of protein candidates in living cells and a machine learning platform to design and optimize therapies for immune activation. The company operates in the immuno-oncology and cell therapy space, aiming to accelerate development of CAR and related therapies.

7 investors

Concert Bio uses DNA sequencing and a microbiome database to identify pathogens and beneficial microbes, then supplies beneficial microbes to hydroponic greenhouse growers to improve crop growth, quality, and yield. It serves hydroponic growers as an agtech platform for optimizing the plant microbiome.

7 investors